Back to results
US 2020/0002667 A1Published application
Biomatrix scaffolds
AssigneeThe University of North Carolina at Chapel Hill
InventorsYunfang Wang, Lola Cynthia McAdams Reid, Mitsuo Yamauchi, Cai-Bin Cui, Andrew Zhuang Wang, Michael Edward Werner
Life of this patent
Estimating the term…
Abstract
The present invention provides biomatrix scaffolds, a tissue extract enriched for extracellular matrix components and bound growth factors, cytokines and hormones, and methods of making and using same.
Claims33
-16. (canceled)
A biomatrix scaffold produced by a method comprising:
- a) perfusing the biological tissue or homogenizing the biological tissue with a first medium, wherein the osmolality of said first medium is from about 250 mOsm/kg to about 350 mOsm/kg and said first medium is serum free and at neutral pH;
- then
- b) perfusing the biological tissue or extracting the homogenate of step (a) with a delipidating buffer comprising lipases and/or detergents in said first medium;
- wherein the detergents do not comprise sodium dodecyl sulfate or Triton X-100;
- then
- c) perfusing the tissue or extracting the homogenate of step (b) with a buffer comprising a pH and a salt concentration, wherein the pH and the salt concentration keep a plurality of collagens in the biological tissue in an insoluble state;
- then
- d) rinsing the tissue or homogenate of step (c) with a second medium that is at neutral pH, is serum-free and has an osomolality from about 250 mOsm/kg to about 350 mOsm/kg;
- thereby producing an intact or homogenized biomatrix scaffold from the biological tissue, said biomatrix scaffold comprising at least 95% of the collagens and most collagen-associated matrix components and matrix bound growth factors, hormones and cytokines of the biological tissue.
6 more elements
-29. (canceled)
-39. (canceled)
-46. (canceled)
Dependencies are inferred from the claim text.